VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Launched by ELI LILLY AND COMPANY · Oct 16, 2012
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Postmenopausal women with osteoporosis, as defined by low bone mineral density (BMD), i.e. anterior-posterior lumbar spine, total hip or femoral neck BMD ≥1.5 standard deviations below the average BMD for young, healthy, non-Hispanic, Caucasian women
- • A minimum of 2 moderate or 1 severe vertebral fragility fractures (confirmed by central reader) were required
- Exclusion Criteria:
- • Increased risk of osteosarcoma
- • History of unresolved skeletal diseases that affect bone metabolism
- • History of atypical subtrochanteric or diaphyseal femoral fractures
- • Abnormally high or low calcium levels
- • Abnormally high parathyroid hormone (PTH) levels
- • Severe vitamin D deficiency
- • Abnormal thyroid function not corrected by therapy
- • History of malignant neoplasms in the last 5 years
- • Active liver disease, clinical jaundice
- • Significant impairment of hepatic or renal function
- • History of nephro- or urolithiasis
- • Previous or planned kypho- or vertebroplasty
- • Active or risk for osteonecrosis of the jaw
- • Active or recent history of upper gastrointestinal disorders
- • Unable to stand or sit in the upright position for at least 30 minutes
About Eli Lilly And Company
Eli Lilly and Company is a global healthcare leader dedicated to creating innovative medicines that improve patient outcomes across a range of therapeutic areas, including diabetes, oncology, immunology, and neurodegenerative diseases. With a rich history of scientific research and a commitment to advancing healthcare, Lilly invests significantly in clinical trials to develop new treatments and enhance existing therapies. The company prioritizes patient safety and ethical standards in its clinical research, fostering collaboration with healthcare professionals and stakeholders to ensure the delivery of high-quality, evidence-based solutions that address unmet medical needs worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Firenze, , Italy
Torino, , Italy
San Juan, , Puerto Rico
Pittsburgh, Pennsylvania, United States
Dallas, Texas, United States
Vancouver, British Columbia, Canada
Leipzig, , Germany
Birmingham, Alabama, United States
Bethesda, Maryland, United States
Indianapolis, Indiana, United States
Padova, , Italy
Asheville, North Carolina, United States
Sabadell, , Spain
Topeka, Kansas, United States
Omaha, Nebraska, United States
Eger, , Hungary
Gent, , Belgium
Genk, , Belgium
Leuven, , Belgium
Gilly, , Belgium
Evansville, Indiana, United States
Rome, , Italy
Barcelona, , Spain
Toulouse, , France
Madrid, , Spain
Concord, California, United States
Fresno, California, United States
Alcira, , Spain
Detroit, Michigan, United States
Albuquerque, New Mexico, United States
Graz, , Austria
Montreal, Quebec, Canada
Prague, , Czechia
Laguna Hills, California, United States
Gainesville, Georgia, United States
Spokane, Washington, United States
Madison, Wisconsin, United States
Rio De Janeiro, , Brazil
Hamilton, Ontario, Canada
Sainte Foy, Quebec, Canada
Trois Rivieres, Quebec, Canada
Saskatoon, Saskatchewan, Canada
Frankfurt, , Germany
Valeggio Sul Mincio, , Italy
Saint Etienne, , France
Brussels, , Belgium
Caen, , France
Orbassano, , Italy
Bend, Oregon, United States
Toronto, Ontario, Canada
Patras, , Greece
Halifax, Nova Scotia, Canada
Lancaster, California, United States
Hamburg, , Germany
Magdeburg, , Germany
Kifissia, , Greece
Brasilia, , Brazil
Kaposvar, , Hungary
Lakewood, Colorado, United States
Orlando, Florida, United States
Tustin, California, United States
Danbury, Connecticut, United States
Greensboro, North Carolina, United States
Seattle, Washington, United States
Duncansville, Pennsylvania, United States
Elblag, , Poland
Fargo, North Dakota, United States
Klatovy, , Czechia
Orleans, , France
Buenos Aires, , Argentina
Debrecen, , Hungary
Linz, , Austria
Szeged, , Hungary
Kelowna, British Columbia, Canada
Athens, , Greece
Freehold, New Jersey, United States
Clifton, New Jersey, United States
Thessaloniki, , Greece
Warsaw, , Poland
Wyomissing, Pennsylvania, United States
Merksem, , Belgium
Marburg, , Germany
Valencia, , Spain
Uherske Hradiste, , Czechia
Bialystok, , Poland
Poznan, , Poland
Dresden, , Germany
Lublin, , Poland
Caba, , Argentina
Mar Del Plata, , Argentina
Hohenems, , Austria
Vienna, , Austria
Laken, , Belgium
Liège, , Belgium
Mons, , Belgium
São Paulo, , Brazil
Ceske Budejovice, , Czechia
La Crau, , France
Lyon, , France
Budapest, , Hungary
Genova Nervi, , Italy
Swidnik, , Poland
Cadiz, , Spain
Patients applied
Trial Officials
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials